Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, education, and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and surgical and dental products to veterinary clinics and universities, including dentistry and companion animal orthopedics under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does Vimian Group AB (VIMIAN) operate in?
Vimian Group AB belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Vimian Group AB (VIMIAN) current stock price?
As of the latest data, Vimian Group AB stock price is SEK 35.45, with a previous close of SEK 35.10. Vimian Group AB gained SEK 0.35 in the last trading session, representing a 1% increase.
What is Vimian Group AB (VIMIAN) current market capitalization?
Vimian Group AB market cap is approximately 18.68 billion.
What is Vimian Group AB (VIMIAN) Earnings Per Share (EPS)?
The trailing EPS is SEK 0.78, and the forward EPS is SEK 0.13.
What is Vimian Group AB (VIMIAN) Price-to-Earnings (P/E) ratio?
Vimian Group AB current P/E ratio is 45.45, with a forward P/E of 268.76.
What is Vimian Group AB (VIMIAN) EBITDA?
Vimian Group AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 339.67 million.
Does Vimian Group AB (VIMIAN) pay dividends?
No. Vimian Group AB does not pay a dividend.
How did Vimian Group AB (VIMIAN) perform in its most recent earnings report?
In the last report (June 30, 2026), Vimian Group AB posted an EPS surprise of -33.33% and a revenue surprise of 1,003.27%.
What is Vimian Group AB (VIMIAN) beta (volatility) score?
Vimian Group AB has a beta of 1.169, meaning its volatility is roughly in line with the market.